Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Quality of Life Research

• Publication date

  2014-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11136-013-0608-1PMID 24395525PMCID PMC4032617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials.

  2013cited by this paper
• Caregiving strain and all-cause mortality: evidence from the REGARDS study.

  2013cited by this paper
• Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

  2012cited by this paper
• Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy

  2012cited by this paper
• Comparison of quality-adjusted survival in patients with advanced renal cell carcinoma receiving first-line treatment with temsirolimus (TEMSR) or interferon-{alpha} (IFN) or the combination of IFN+TEMSR

  2007cited by this paper
• The health-related quality-of-life impact of chronic conditions varied with age in general population.

  2007cited by this paper
• Estimating the quality-of-life-adjusted gap time distribution of successive events subject to censoring

  2006cited by this paper
• Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients*

  2006cited by this paper
• Survival and quality of life of patients requiring acute renal replacement therapy

  2005cited by this paper
• Creating an aggregate outcome index: Cost-effectiveness analysis of substance abuse treatment

  2004cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Evaluating Quality-Adjusted Life Years

  2001cited by this paper
• Using the years-of-healthy-life measure to calculate QALYs.

  2001cited by this paper
• A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.

  1999cited by this paper
• Nonparametric estimation of the gap time distributions for serial events with censored data

  1999cited by this paper
• Quality adjusted survival analysis with repeated quality of life measures.

  1998cited by this paper
• A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure

  1998cited by this paper
• A consistent estimator for the distribution of quality adjusted survival time

  1997cited by this paper
• Comparing Treatments Using Quality-Adjusted Survival: The Q-TWiST Method

  1995cited by this paper
• Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo.

  1993cited by this paper
• Quality adjusted survival analysis.

  1990cited by this paper
• Utilities and Quality-Adjusted Life Years

  1989cited by this paper
• Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

  1989cited by this paper
• Large Sample Behaviour of the Product-Limit Estimator on the Whole Line

  1983cited by this paper

• A Comparison of Quality-Adjusted Life Years in Older Adults after Heart Transplantation Versus Long-Term Mechanical Support: Findings From the SUSTAIN-IT study.

  2024cites this paper